SD 0006
Product Specifications
UNSPSC Description
SD 0006 (SD-06) is an orally active, selective, ATP-competitive and potent diaryl pyrazole inhibitor of p38α MAP kinase, with an IC50 of 110 nM for p38α[1][2].
Target Antigen
Autophagy; p38 MAPK
Type
Reference compound
Related Pathways
Autophagy;MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/SD-06.html
Purity
98.73
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OCC(N1CCC(CC1)C2=NNC(C3=CC=C(C=C3)Cl)=C2C4=NC=NC=C4)=O
Molecular Weight
397.86
References & Citations
[1]Burnette BL, et al. SD0006: a potent, selective and orally available inhibitor of p38 kinase. Pharmacology. 2009;84(1):42-60.|[2]Walker JK, et al. Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase. Bioorg Med Chem Lett. 2010 Apr 15;20(8):2634-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-11087/SD-0006-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-11087/SD-0006-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
271576-80-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6313180-01 0.1 mL
KIAA1688, CT (ARHGAP39, KIAA1688, Rho GTPase-activating protein 39) (MaxLight 750)
Ask
View Details 
MBS6313180-02 5x 0.1 mL
KIAA1688, CT (ARHGAP39, KIAA1688, Rho GTPase-activating protein 39) (MaxLight 750)
Ask
View Details 
